Time to Revisit a Voluntary FDA Comparative Effectiveness Pathway.

•  
• Overview
•  
• Research
•  
• Identity
•  
• Additional Document Info
•  
• View All
•  

Overview

authors

• Miller, Brian J
• Gowda, Vrushab
• Jodi Segal, MD, MPH

publication date

• January 1, 2021

published in

• Therapeutic innovation & regulatory science  Journal

Research

Keywords

• Comparative effectiveness research
• FDA regulation
• Innovation
• Real world evidence

Identity

Digital Object Identifier (DOI)

• https://doi.org/10.1007/s43441-021-00261-4

PubMed ID

• 33569676

Additional Document Info

start page

• 643

end page

• 645

volume

• 55

issue

• 4